Market Tracker

04/28 5:16pm ET

Galena Biopharma Inc (NASDAQ:GALE)

0.5901
Delayed Data
As of Apr 28
 -0.0325 / -5.22%
Today’s Change
0.53
Today|||52-Week Range
49.80
-69.58%
Year-to-Date
Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss
Apr 28 / Zacks.com - Paid Partner Content
Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View
Apr 27 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Q1 Earnings Beat, Revenues Meet Estimates
Apr 28 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Galena Biopharma, EVINE Live, Sanchez Production Partn...
Apr 21 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Q1 Loss Wider than Expected, Sales Miss
Apr 28 / Zacks.com - Paid Partner Content
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up
Apr 20 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Apr 27 / Zacks.com - Paid Partner Content
Bet on Rising P/E with These 5 Top-Ranked Stocks
Apr 20 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Beats Q1 Earnings, Revenue Estimates
Apr 27 / Zacks.com - Paid Partner Content
Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III
Apr 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.62
Today’s open0.61
Day’s range0.59 - 0.64
Volume577,312
Average volume (3 months)2,148,010
Market cap--
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
--
Industry
--
No executives to display
Corporate headquarters
--, --

Forecasts